Hypoglycaemia during Treatment of Type 2 Diabetes: Dangerous Complication..... But Avoidable with Modern Non-Insulin Therapy

Authors

  • R Ashok Chandra Rao SUT Academy of Medical Sciences, Vencode, Trivandrum Author
  • D Dinesh Prabhu SUT Academy of Medical Sciences, Vencode, Trivandrum Author

Keywords:

Hypoglycaemia, Type 2 diabetes, Pioglitazone, GLP-1 mimetics, DPP4 inhibitors, SGLT2 inhibitors

Abstract

Hypoglycaemia is a dangerous complication that could occur while treating diabetes. Inpatients with type 2 diabetes, avoidance of hypoglycaemia is desirable in all; and absolutely necessary in many. Currently, clinicians have access to a variety of medications that achieve the dual objective of reaching targets and avoiding hypoglycaemia.  

This brief review aims to highlight the dangers of hypoglycaemia and to familiarize clinicians with non-insulin based medications that avoid hypoglycaemia while treating patients with type 2 diabetes mellitus.

Author Biographies

  • R Ashok Chandra Rao , SUT Academy of Medical Sciences, Vencode, Trivandrum

    Associate Professor, Department of Medicine

  • D Dinesh Prabhu , SUT Academy of Medical Sciences, Vencode, Trivandrum

    Assistant Professor, Consultant Diabetologist, Department of Medicine

Downloads

Published

2016-09-29

Issue

Section

Review Article

Similar Articles

1-10 of 66

You may also start an advanced similarity search for this article.